NIH Recombinant DNA Guidelines

This course offers training on the National Institutes of Health (NIH) Guidelines for Research Involving Recombinant and Synthetic Nucleic Acid Molecules requirements.

Organizations
LEARN MORE
New Subscribers Current Subscribers
Learners BUY NOW
Interested? Demo Course
Scroll Down Arrow

About this Course

NIH Recombinant DNA Guidelines provides principal investigators and those responsible for the conduct of recombinant and synthetic nucleic acid research experiments with basic training and an overview of the requirements established by the National Institutes of Health (NIH).

View Series Page for FAQs

Language Availability: English

Suggested Audiences: Principal Investigators and Researchers Responsible for the Conduct of Recombinant and Synthetic Nucleic Acid Research Experiments

Organizational Subscription Price: Included in Biosafety and Biosecurity Comprehensive series, available as part of an organizational subscription package or for $1,080 per year/per site as a subscription add-on for government and non-profit organizations; $1,200 per year/per site as a subscription add-on for for-profit organizations
Independent Learner Price: $110 per person

Course Content

NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules

Provides principal investigators and others responsible for the conduct of recombinant and synthetic nucleic acid research experiments, and Institutional Biosafety Committee (IBC) members who review these experiments, with training on the requirements of the National Institutes of Health (NIH) Guidelines for Research Involving Recombinant and Synthetic Nucleic Acid Molecules. It is designed as initial training but can also be used as periodic refresher training for principal investigators and IBC members as required by the NIH guidelines.

Recommended Use: Required
ID (Language): 13493 (English)
Author(s): Benjamin Fontes, MPH, CBSP - Yale University

Dual Use Research of Concern (DURC)

Detailed training on the Oversight of Dual Use Research of Concern and Pathogens with Enhanced Pandemic Potential.  It describes the agents and types of experiments that require oversight. Identifies the responsibilities of principal investigators, federally funded research institutions, federal funding agencies, and institutional contract for dual use research (ICDURC).

Important Notice: The U.S. Government Policy for Stopping High-Risk Life Sciences Research, released in July 2026, establishes a new framework for the oversight of certain high-risk life sciences research and replaces previous federal DURC oversight policies. CITI Program is reviewing the policy and considering its implications for this course and related educational resources.

Recommended Use: Supplemental
ID (Language): 16263 (English)
Author(s): Melissa James, MPS, RBP - Yale University

Learn More

This field is for validation purposes and should be left unchanged.
Your Name(Required)
I am looking for technical support. Visit our Support Center.
This field is hidden when viewing the form
I'd Like To Receive Emails From CITI Program